Xandr Universal Pixel

Prenatal Screening Cystic Fibrosis (60) Mutation

Genesys Diagnostics
SKU: GDI01

$489.00 per test

Help people who want to determine the risk of cystic fibrosis prenatally by using the latest next generation sequencing because unlike any other Clinical Diagnostics marketplace Meenta offers unfettered access to validated tests.

 

 

 

 

 

Help people who want to determine the risk of cystic fibrosis prenatally by using the latest next generation sequencing because unlike any other Clinical Diagnostics marketplace Meenta offers unfettered access to validated tests.

 

 

 

 

 

The Fine Print

Purpose: Detect risk of cystic fibrosis prenatally

Benefits:

  • Analyzes genes involved in cystic fibrosis
  • Helps inform helpful healthcare and lifestyle changes
  • Reveals genetic risk in yourself and close relatives
  • Comprehensive genetic test
  • Outlines hereditary mutations that can reveal increased risk to future generations

Sample type: Cheek swab

Technology: Next Generation Sequencing

Turnaround time: 3-4 weeks from receipt in lab

Cystic fibrosis (also called CF) is a condition that causes thick mucus to build up in the body. This causes problems with breathing and digestion.  Symptoms vary but result in chronic pulmonary and gastrointestinal/pancreatic disease

If there is a chance a parent-to-be may pass the Cystic fibrosis gene to an offspring, you you may want to get  tested because your obstetrician may need to change treatment or medicine that’s safer for your baby.  Working with your obstetrician usually leads to a healthy pregnancy.

Both parents must be carriers to pass this gene onto their child. If both are carriers, there is a 25% chance the child will be affected with each pregnancy. It is recommended that if couple are positive for the gene that they seek genetic counseling.

 
 

How do I interpret the results?

Genetic counseling is generally recommended for any individual taking this test and their family. A medical provider can request reanalysis of the variants, and this is recommended on an annual basis. Data from this next-generation sequencing analysis can be reassessed for the presence of any new variants that may be newly linked to established genes or to newly characterized genes and/or disorders identified since the data used in this report was generated. A charge may be applied for reanalysis. Please contact support@meenta.io for more information at the time reanalysis is requested.
Cheek swab in viral transport media shipped at room temperature

  • No products in the cart.